Safilo Group S.p.A. (SAFLY)
OTCMKTS · Delayed Price · Currency is USD
2.290
+0.060 (2.69%)
At close: Jul 1, 2025
FARO Technologies Revenue
Safilo Group had revenue of 461.26M EUR in the half year ending December 31, 2024, a decrease of -8.82%. This brings the company's revenue in the last twelve months to 998.89M, down -0.76% year-over-year. In the year 2024, Safilo Group had annual revenue of 993.22M, down -3.08%.
Revenue (ttm)
998.89M EUR
Revenue Growth
-0.76%
P/S Ratio
0.50
Revenue / Employee
274.04K EUR
Employees
3,645
Market Cap
583.50M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 993.22M | -31.51M | -3.08% |
Dec 31, 2023 | 1.02B | -52.01M | -4.83% |
Dec 31, 2022 | 1.08B | 107.16M | 11.05% |
Dec 31, 2021 | 969.58M | 189.29M | 24.26% |
Dec 31, 2020 | 780.30M | -158.74M | -16.90% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |